Literature DB >> 14603338

BRAF mutations in acute leukemias.

J W Lee, Y H Soung, W S Park, S Y Kim, S W Nam, W S Min, J Y Lee, N J Yoo, S H Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14603338     DOI： 10.1038/sj.leu.2403201

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

Review 2.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

3.  A critical function for B-Raf at multiple stages of myelopoiesis.

Authors:  Tamihiro Kamata; Jing Kang; Tzong-Hae Lee; Leszek Wojnowski; Catrin A Pritchard; Andrew D Leavitt
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

Review 4.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

Review 5.  Aberrant cytokine signaling in leukemia.

Authors:  R A Van Etten
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

6.  Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts.

Authors:  Kathryn Mercer; Susan Giblett; Stuart Green; David Lloyd; Silvy DaRocha Dias; Mark Plumb; Richard Marais; Catrin Pritchard
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

Review 7.  Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples.

Authors:  Esther Diana Rossi; Maurizio Martini; Tommaso Bizzarro; Fernando Schmitt; Adhemar Longatto-Filho; Luigi Maria Larocca
Journal:  Oncotarget       Date:  2017-01-10

Review 8.  Comparative Aspects of BRAF Mutations in Canine Cancers.

Authors:  Hiroyuki Mochizuki; Matthew Breen
Journal:  Vet Sci       Date:  2015-08-24

9.  Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720.

Authors:  Tamihiro Kamata; David Dankort; Jing Kang; Susan Giblett; Catrin A Pritchard; Martin McMahon; Andrew D Leavitt
Journal:  Mol Cancer Res       Date:  2013-10-23       Impact factor: 5.852

10.  RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.

Authors:  Francianne Gomes Andrade; Juliana Montibeller Furtado-Silva; Bruno Alves de Aguiar Gonçalves; Luiz Claudio Santos Thuler; Thayana Conceição Barbosa; Mariana Emerenciano; André Siqueira; Maria S Pombo-de-Oliveira
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.